Patent · US Active

Particles

US12138362B2 · kind B2 · utility

0Cited by
0References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 15, 2023
Grant dateNov 12, 2024
Priority date
Expiry dateNov 15, 2043

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2430/36
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Embolic particles are described. The particles are reaction products of a prepolymer solution including at least one polyether macromer and an appropriate monomer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.